Company: BIAF
Filing Date: 2025-04-11
Form Type: S-1
Source: 0001641172-25-003892
Chunk: 72

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-11
Form: S-1
Chunk 72
---
whether brought against a party to the warrant certificate or their respective affiliates, directors, officers, shareholders, partners,
members, employees, or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. The warrant
certificates further provide that we and the warrant holders irrevocably submit to the exclusive jurisdiction of the state and federal
courts sitting in the City of New York, Borough of Manhattan, for the adjudication of any dispute under the warrant certificate or in
connection with it or with any transaction contemplated by it or discussed in it. Furthermore, we and the warrant holders irrevocably
waive, and agree not to assert in any suit, action, or proceeding, any claim that we or they are not personally subject to the jurisdiction
of any such court, that such suit, action, or proceeding is improper or is an inconvenient venue for such proceeding. With respect to
any complaint asserting a cause of action arising under the Securities Act or the rules and regulations promulgated thereunder, we note,
however, that there is uncertainty as to whether a court would enforce this provision and that investors cannot waive compliance with
the federal securities laws and the rules and regulations thereunder. Section 22 of the Securities Act creates concurrent jurisdiction
for state and federal courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations
thereunder. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability
created by the Exchange Act or the rules and regulations thereunder. As a result, the exclusive forum provision in the warrant certificates
expressly does not apply to suits brought to enforce any duty or liability created by the Exchange Act.

Any person or entity purchasing or otherwise acquiring
or holding or owning (or continuing to hold or own) any interest in any of our warrants shall be deemed to have notice of and consented
to the foregoing provisions. Although we believe this exclusive forum provision benefits us by providing increased consistency in the
application of the governing law in the types of lawsuits to which it applies, the exclusive forum provision may limit a warrant holder’s
ability to bring a claim in a judicial forum of its choosing for disputes with us or any of our directors, officers, other employees,
stockholders, or others which may discourage lawsuits with respect to such claims. Our warrant holders will not be deemed to have waived
our compliance with the federal securities laws and the rules and regulations thereunder as